Does methylphenidate reduce the symptoms of chronic fatigue syndrome?

American Journal of Medicine

Volumn 119, Issue 2, 2006, Pages 167.e23-167.e30

  Blockmans, Daniel ^a   Persoons, Philippe ^a   Van Houdenhove, Boudewijn ^a   Bobbaers, Herman ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Chronic fatigue syndrome; Concentration difficulties; Fatigue; Methylphenidate

Indexed keywords

METHYLPHENIDATE; PLACEBO;

AKATHISIA; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FATIGUE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SLEEP DISORDER; THORAX PAIN; VISUAL ANALOG SCALE; XEROSTOMIA;

EID: 31444449330     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.07.047     Document Type: Article

References (31)

1. K. Fukuda, S.E. Straus, I. Hickie, M.C. Sharpe, J.G. Dobbins, A. Komaroff The chronic fatigue syndrome a comprehensive approach to its definition and study Ann Intern Med 121 1994 953 959
2. H.L. Wallace, B. Natelson, W. Gause, J. Hay Human herpes viruses in chronic fatigue syndrome Clin Diagn Lab Immunol 3 1999 216 223
3. M. Nasralla, J. Haier, G.L. Nicolson Multiple mycoplasmal infections detected in blood of patients with chronic fatigue syndrome and/or fibromyalgia syndrome Eur J Clin Microbiol Infect Dis 18 1999 859 865
4. A.J. Cleare The neuroendocrinology of chronic fatigue syndrome Endocr Rev 24 2003 236 252
5. A. Skowera, A. Cleare, D. Blair, L. Bevis, S.C. Wessely, M. Peakman High levels of type 2 cytokine-producing cells in chronic fatigue syndrome Clin Exp Immunol 135 2004 294 302
6. P.C. Rowe, H. Calkins Neurally mediated hypotension and chronic fatigue syndrome Am J Med 105 1998 15S 21S
7. R.J. Suhadolnik, D.L. Peterson, K. O'Brien Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome J Interferon Cytokine Res 17 1997 377 385
8. P. Whiting, A.M. Bagnall, A.J. Sowden, J.E. Cornell, C.D. Mulrow, G. Ramirez Interventions for the treatment and management of chronic fatigue syndrome. A systematic review JAMA 286 2001 1360 1368
9. D. Blockmans, P. Persoons, B. Van Houdenhove, M. Lejeune, H. Bobbaers Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome a randomized, placebo-controlled, double-blind, crossover study Am J Med 114 2003 736 741
10. S. Wessely, C. Nimnuan, M. Sharpe Functional somatic syndromes one or many? Lancet 354 1999 936 939
11. D.J. Clauw, G.P. Chrousos Chronic pain and fatigue syndromes overlapping clinical and neuroendocrine features and potential pathogenic mechanisms Neuroimmunomodulation 4 1997 134 153
12. M. Edmonds, H. McGuire, J. Price Exercise therapy for chronic fatigue syndrome Cochrane Database Syst Rev 3 2004 CD003200
13. Y. Sugawara, T. Akechi, Y. Shima Efficacy of methylphenidate for fatigue in advanced cancer patients a preliminary study Palliat Med 16 2002 261 263
14. N. Sarhill, D. Walsh, K.A. Nelson Methylphenidate for fatigue in advanced cancer a prospective open-label pilot study Am J Hosp Palliat Care 18 2001 187 192
15. E. Bruera, L. Driver, E.A. Barnes Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer a preliminary report J Clin Oncol 21 2003 4439 4443
16. W. Breitbart, B. Rosenfeld, M. Kaim, J. Funesti-Esch A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease Arch Intern Med 161 2001 411 420
17. D. Banerjee, M.V. Vitiello, R.R. Grunstein Pharmacotherapy for excessive daytime sleepiness Sleep Med Rev 8 2004 339 354
18. H. Abikoff, L. Hechtman, R.G. Klein Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment J Am Acad Child Adolesc Psychiatry 43 2004 802 811
19. World Health Organisation SCAN Schedules for Clinical Assessment in Neuropscyiatry, Version 2.0 1994 Psychiatric Publishers International/American Psychiatric Press Geneva, Switzerland
20. J.H. Vercoulen, C.M. Swanink, J.F. Fennis, J.M. Galama, J.W. van der Meer, G. Bleijenberg Dimensional assessment of chronic fatigue syndrome J Psychosom Res 38 1994 383 392
21. J. Vercoulen, M.G.B. Alberts De Checklist Individual Strength (CIS) Gedragstherapie 32 1999 131 136
22. U. Bultmann, M. de Vries, A.J. Beurskens, G. Bleijenberg, J.H. Vercoulen, I. Kant Measurement of prolonged fatigue in the working population determination of a cutoff point for the checklist individual strength J Occup Health Psychol 5 2000 411 416
23. J.E. Ware SF-36 health survey update Spine 25 2000 3130 3139
24. A.S. Zigmond, R.P. Snaith The hospital anxiety and depression scale Acta Psychiatr Scand 67 1983 361 370
25. I. Bjelland, A. Dahl, T. Haug, D. Neckelmann The validity of the Hospital Anxiety and Depression Scale. An updated literature review J Psychosom Res 52 2002 69 77
26. H.J. Cho, M. Hotopf, S. Wessely The placebo response in the treatment of chronic fatigue syndrome a systematic review and meta-analysis Psychosom Med 67 2005 301 313
27. L.G. Olson, A. Ambrogetti, D.C. Sutherland A pilot randomized controlled trial of dexamphetamine in patients with chronic fatigue syndrome Psychosomatics 44 2003 38 43
28. N.D. Volkow, J.S. Fowler, G.-J. Wang, Y.-S. Ding, S.J. Gatley Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans results from imaging studies Eur Neuropsychopharmacol 12 2002 557 566
29. B.E. Leonard, D. McCartan, J. White, D.J. King Methylphenidate a review of its neuropharmacological, neuropsychological and adverse clinical effects Hum Psychopharmacol 19 2004 151 180
30. N.D. Volkow, G.J. Wang, J.S. Fowler Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain Am J Psychiatry 161 2004 1173 1180
31. S.H. Kollins Comparing the abuse potential of methylphenidate versus other stimulants a review of available evidence and relevance to the ADHD patient J Clin Psychiatry 64 suppl 11 2003 14 18